Ads
related to: gilenya multiple sclerosis treatment- Switching to VUMERITY®
Consider Another Option
For Your Patients With VUMERITY®.
- Learning Tools for HCPs
Learn More About
VUMERITY® Through MOA Data.
- E-Sign Start Form
Download a VUMERITY® Start
Form & Begin Prescribing Patients.
- Getting Started
Help Your Patients Get Started
On VUMERITY® As A Therapy Option.
- Coverage & Access Info
View VUMERITY® Copay &
Insurance Coverage Information.
- VUMERITY® Efficacy
Learn More About The Efficacy Of
VUMERITY® Across 2 Pivotal Trials.
- Switching to VUMERITY®
Search results
Is Biogen a Smart Biotech Stock to Buy Right Now?
Motley Fool· 2 years agoTens of millions of Alzheimer's disease patients were given a rare dose of good news recently when Biogen (NASDAQ: BIIB) released some encouraging...
How Novartis' Laggard Business Was Its Second-Quarter Saving Grace
Investor's Business Daily· 2 years agoSwiss drugmaker Novartis delivered a mixed second-quarter report Tuesday, but Novartis stock popped...
Novartis Breaks Out After Putting Up Its Best Profit Growth In Two Years
Investor's Business Daily· 10 months agoNovartis stock broke out Tuesday after the Big Pharma stalwart put up its best profit growth in two...
Novartis Planning to Bring Dispute Over Drug Patent to U.S. Supreme Court
Investing.com via Yahoo Finance· 2 years agoBy Scott Kanowsky Investing.com -- Novartis AG (SIX:NOVN) says it plans to petition the U.S. Supreme Court to uphold the validity of its patent for a dosing regimen of its blockbuster multiple ...
Novartis, helped by cost cuts, raises full-year outlook
Reuters via Yahoo Finance· 1 year agoFRANKFURT (Reuters) -Novartis on Tuesday raised its full-year earnings outlook following cost cuts,...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 1 month agoSwiss pharma giant Novartis AG NVS reported better-than-expected results for the first quarter of...
Novartis (NVS) Q4 Earnings Miss on Higher Costs, Sales Lag
Zacks via Yahoo Finance· 4 months agoSwiss pharma giant Novartis AG NVS reported lower-than-expected results in the fourth quarter of...
Ads
related to: gilenya multiple sclerosis treatment